| Business Summary | | Laserscope
manufactures,
sells
and
services
a
line
of
medical
laser
systems
and
related
energy
devices
for
the
medical
office,
outpatient
surgical
center
and
hospital
markets.
The
Company's
product
portfolio
consists
of
more
than
350
products,
including
KTP/532,
CO2,
Nd:YAG,
Er:YAG,
and
Dye
medical
laser
systems
and
related
energy
delivery
devices.
The
Company's
primary
medical
markets
include
dermatology,
aesthetic
surgery
and
urology.
Its
secondary
markets
include
ear,
nose
and
throat
surgery,
general
surgery,
gynecology
and
photodynamic
therapy. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Laserscope
develops,
manufactures,
markets
and
support
surgical
lasers
and
other
surgical
systems,
related
instrumentation
and
disposable
supplies.
For
the
six
months
ended
6/30/01,
revenues
fell
2%
to
$17.5
million.
Net
loss
totaled
$308
thousand,
up
from
$49
thousand.
Revenues
suffered
from
a
decrease
in
the
average
selling
prices.
Higher
loss
also
reflects
higher
start-up
expenses
such
as
workshops
and
marketing
material
to
support
the
McKesson
distribution
agreement. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Robert Pressley, Ph.D., 68 Chairman | -- | -- | Eric Reuter, 39 Pres,
CEO, Director | $238K | -- | Dennis LaLumandiere, 47 CFO,
VP-Fin., Assistant Sec. | 176K | -- | Robert Mathews, 55 Exec.
VP | 183K | $1.2K | Kevin Candio, 47 Sr.
VP, Global Sales | 206K | 0.4K | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|